Clariant Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Clariant ha aumentado sus ingresos a un ritmo medio anual de 2.1%, mientras que la industria Chemicals ha visto aumentar sus ingresos growing a 12.9% anualmente. Los ingresos han crecido growing a un ritmo medio anual de 3.1%. Clariant La rentabilidad de los fondos propios de la empresa es de 9.8% y sus márgenes netos son de 4.9%.

Información clave

0.2%

Tasa de crecimiento de los beneficios

0.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 6.0%
Tasa de crecimiento de los ingresos3.1%
Rentabilidad financiera9.8%
Margen neto3.8%
Próxima actualización de resultados30 Apr 2024

Actualizaciones de resultados anteriores recientes

Recent updates

What Is Clariant AG's (VTX:CLN) Share Price Doing?

Apr 23
What Is Clariant AG's (VTX:CLN) Share Price Doing?

Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now

Apr 03
Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now

An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued

Nov 22
An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued

Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt

Oct 31
Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt

Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly

Jul 30
Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly

Is Now The Time To Look At Buying Clariant AG (VTX:CLN)?

May 12
Is Now The Time To Look At Buying Clariant AG (VTX:CLN)?

These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Reasonably Well

Apr 08
These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Reasonably Well

Should You Think About Buying Clariant AG (VTX:CLN) Now?

Dec 23
Should You Think About Buying Clariant AG (VTX:CLN) Now?

We Think Clariant (VTX:CLN) Can Stay On Top Of Its Debt

Dec 05
We Think Clariant (VTX:CLN) Can Stay On Top Of Its Debt

Why Clariant AG (VTX:CLN) Could Be Worth Watching

Sep 23
Why Clariant AG (VTX:CLN) Could Be Worth Watching

Is It Time To Consider Buying Clariant AG (VTX:CLN)?

May 17
Is It Time To Consider Buying Clariant AG (VTX:CLN)?

At CHF17.29, Is It Time To Put Clariant AG (VTX:CLN) On Your Watch List?

Feb 15
At CHF17.29, Is It Time To Put Clariant AG (VTX:CLN) On Your Watch List?

Should You Think About Buying Clariant AG (VTX:CLN) Now?

Nov 07
Should You Think About Buying Clariant AG (VTX:CLN) Now?

Is Clariant (VTX:CLN) Using Too Much Debt?

Oct 03
Is Clariant (VTX:CLN) Using Too Much Debt?

Should You Investigate Clariant AG (VTX:CLN) At CHF18.84?

Aug 01
Should You Investigate Clariant AG (VTX:CLN) At CHF18.84?

Here's Why Clariant (VTX:CLN) Can Manage Its Debt Responsibly

May 20
Here's Why Clariant (VTX:CLN) Can Manage Its Debt Responsibly

Why Clariant AG (VTX:CLN) Could Be Worth Watching

Apr 29
Why Clariant AG (VTX:CLN) Could Be Worth Watching

Does Clariant AG's (VTX:CLN) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?

Mar 04
Does Clariant AG's (VTX:CLN) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?

A Look At Clariant's (VTX:CLN) Share Price Returns

Feb 11
A Look At Clariant's (VTX:CLN) Share Price Returns

We're Not Counting On Clariant (VTX:CLN) To Sustain Its Statutory Profitability

Jan 20
We're Not Counting On Clariant (VTX:CLN) To Sustain Its Statutory Profitability

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Clariant. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SWX:CLN Ingresos, gastos y beneficios (CHF Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 234,377168655138
30 Jun 234,919-98684142
31 Mar 235,059-115718146
31 Dec 225,198-133752150
30 Sep 225,050107733154
30 Jun 224,901346713157
31 Mar 224,637305708157
31 Dec 214,372263702156
30 Sep 214,161199676158
30 Jun 213,949135649159
31 Mar 213,905121665159
31 Dec 203,860106681159
30 Jun 204,1151411,010166
31 Mar 204,257401,019171
31 Dec 194,399-621,027175
30 Jun 194,409-67865176
31 Mar 194,40764861175
31 Dec 184,404194856174
30 Sep 184,937223922182
30 Jun 185,469251987190
31 Mar 185,9232641,072197
31 Dec 176,3772771,157203
30 Sep 176,2292761,130201
30 Jun 176,0802741,102199
31 Mar 175,9642641,093199
31 Dec 165,8472531,084199
30 Sep 165,8992111,083208
30 Jun 165,8352031,092208
31 Mar 165,7921951,063207
31 Dec 155,8072171,067204
30 Sep 155,8672751,064199
30 Jun 155,9642721,061203
31 Mar 156,0892991,076208
31 Dec 146,1161751,049213
30 Sep 146,0931771,058212
30 Jun 146,0292451,024208
31 Mar 146,0422311,039203
31 Dec 136,0763061,049199
30 Sep 136,0223091,023197
30 Jun 136,0682301,065188

Ingresos de calidad: CLN tiene un gran one-off loss de CHF183.0M impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.

Margen de beneficios creciente: CLN fueron rentables en el pasado.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: CLNLos beneficios de la empresa han crecido un 2.1% al año en los últimos 5 años.

Acelerando crecimiento: CLN ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su media de 5 años.

Beneficios vs. Industria: CLN ha pasado a ser rentable en el último año, lo que hace difícil comparar el crecimiento de sus beneficios en el último año con el del sector Chemicals (-17.8%).


Rentabilidad financiera

Alta ROE: El Retorno sobre el capital de CLN (9.8%) se considera bajo.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target